Skip to main content
Journal cover image

Polypharmacy in Adults With Systemic Lupus Erythematosus.

Publication ,  Journal Article
Yang, J; Growdon, ME; Fitzpatrick, J; Dunlop-Thomas, C; Hoge, C; Covinsky, KE; Bowling, CB; Lim, SS; Yazdany, J; Plantinga, LC
Published in: Arthritis Care Res (Hoboken)
October 24, 2025

OBJECTIVE: Estimates of polypharmacy among US adults with systemic lupus erythematosus (SLE)-a relatively young and disproportionately minoritized population-remain sparse. We sought to estimate the prevalence of polypharmacy in SLE and identify the most common medications used. METHODS: For this cross-sectional study, participants were recruited from a population-based cohort of adults with validated SLE in Atlanta, Georgia. Prescription and over-the-counter (OTC) medications were self-reported at the study visit. Polypharmacy was defined as five or more prescription or OTC medications. Estimates of polypharmacy prevalence by key sociodemographic and SLE-related participant characteristics were obtained using crude logistic regression and postestimation marginals. RESULTS: More than half (56.3%) of participants (n = 451; 15.3% ≥60 years old, 91.8% women, and 81.8% Black) reported polypharmacy. Older age (68.1%, 59.8%, and 43.0% for ages ≥60 years, 40-59 years, and 18-39 years), higher vs lower disease activity (65.8% vs 46.2%) and cumulative SLE-related damage (68.5% vs 42.4%), longer disease duration (62.4% vs 50.0%), and taking three to five vs zero to one immunomodulating medications (79.6% vs 38.0%) were associated with higher age-adjusted prevalence of polypharmacy; prevalence was not statistically significantly different by sex, race, or education. Although hydroxychloroquine (71.4%), glucocorticoids (44.3%), and other immunomodulating drugs (50.3%) were common, polypharmacy was most often driven by other medications, such as antihypertensives (61.9%), nonopioid pain relievers (51.7%), allergy treatments (22.4%), antidepressants (22.2%), and gastric reflux medications (21.7%). CONCLUSION: Our results underscore the need to address the burden of medication regimens in this population through individualized medication optimization strategies that account for prescription and OTC medications used by those with SLE.

Duke Scholars

Published In

Arthritis Care Res (Hoboken)

DOI

EISSN

2151-4658

Publication Date

October 24, 2025

Location

United States

Related Subject Headings

  • 4201 Allied health and rehabilitation science
  • 3202 Clinical sciences
  • 1701 Psychology
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Yang, J., Growdon, M. E., Fitzpatrick, J., Dunlop-Thomas, C., Hoge, C., Covinsky, K. E., … Plantinga, L. C. (2025). Polypharmacy in Adults With Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). https://doi.org/10.1002/acr.25686
Yang, Jianing, Matthew E. Growdon, Jessica Fitzpatrick, Charmayne Dunlop-Thomas, Courtney Hoge, Kenneth E. Covinsky, C Barrett Bowling, S Sam Lim, Jinoos Yazdany, and Laura C. Plantinga. “Polypharmacy in Adults With Systemic Lupus Erythematosus.Arthritis Care Res (Hoboken), October 24, 2025. https://doi.org/10.1002/acr.25686.
Yang J, Growdon ME, Fitzpatrick J, Dunlop-Thomas C, Hoge C, Covinsky KE, et al. Polypharmacy in Adults With Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). 2025 Oct 24;
Yang, Jianing, et al. “Polypharmacy in Adults With Systemic Lupus Erythematosus.Arthritis Care Res (Hoboken), Oct. 2025. Pubmed, doi:10.1002/acr.25686.
Yang J, Growdon ME, Fitzpatrick J, Dunlop-Thomas C, Hoge C, Covinsky KE, Bowling CB, Lim SS, Yazdany J, Plantinga LC. Polypharmacy in Adults With Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). 2025 Oct 24;
Journal cover image

Published In

Arthritis Care Res (Hoboken)

DOI

EISSN

2151-4658

Publication Date

October 24, 2025

Location

United States

Related Subject Headings

  • 4201 Allied health and rehabilitation science
  • 3202 Clinical sciences
  • 1701 Psychology
  • 1117 Public Health and Health Services
  • 1103 Clinical Sciences